fda drug shortages semaglutide injection shortage resolved 2025 Hims & Hers stock falls 25% as curtails compounded GLP-1s Novo's Wegovy and Ozempic removed

The European Medicines Agency recommends evaluating treatment response at 12 weeks and continuing only if the patient achieves at least 5% body weight reduction

This is the first published trial to study the impact of a GLP-1 RA in a population with significant CKD, and it supports the renal benefits that had previously been suggested in some of the GLP-1 RA cardiovascular outcome trials

(3) Reducing Inflammation (3) Reducing Inflammation Inflammation is a natural part of the immune response, but chronic inflammation can be harmful

A recent population-based cohort study involving over 7,000 participants examined the influence of thyroid function on cardiovascular disease and mortality

Clin Dermatol 22(2):129138

Nausea, vomiting, diarrhea, and severe appetite suppression can become unbearable at higher tirzepatide doses, particularly at 10 mg, 12.5 mg, and 15 mg